We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > INNA-051

News List

Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals prnasia
December 18, 2020
Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in a gold standard ferret study, has been published in two leading international peer-reviewed journals.
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study prnasia
September 28, 2020
A novel nasal treatment developed to boost the natural human immune system to fight common colds and flu, has proved remarkably successful in reducing COVID-19 viral replication test results, released today, reveal.